Inventor · disambiguated record
John Robert Pollard
Also filed as: POLLARD JOHN · POLLARD JOHN R · POLLARD JOHN ROBERT
10 granted patents·15 pending applications·67 citations·filing 2006–2023
87Inventor score
Top patents by PatentIndex Score
25 records- 0195US9791456B2Method for measuring ATR inhibition mediated increases in DNA damageVERTEX PHARMA·Filed 2015·Granted Oct 17, 2017·17 cites·17 claims
- 0295US8999632B2Method for measuring ATR inhibition mediated increases in DNA damageVERTEX PHARMA·Filed 2013·Granted Apr 7, 2015·40 cites·5 claims
- 0385US9983219B2Biomarkers for seizuresUNIV PENNSYLVANIA·Filed 2017·Granted May 29, 2018·2 cites·6 claims
- 0484US11110086B2Compounds useful as inhibitors of ATR kinase and combination therapies thereofVERTEX PHARMA·Filed 2019·Granted Sep 7, 2021·1 cites·20 claims
- 0584US10813929B2Treating cancer with ATR inhibitorsVERTEX PHARMA·Filed 2014·Granted Oct 27, 2020·2 cites·1 claims
- 0681US10478430B2Compounds useful as inhibitors of ATR kinase and combination therapies thereofVERTEX PHARMA·Filed 2015·Granted Nov 19, 2019·3 cites·20 claims
- 0780US11598782B2Biomarkers and methods for detection of seizures and epilepsyEVOGEN INC·Filed 2020·Granted Mar 7, 2023·2 cites·7 claims
- 0871US2022233521A1Compounds useful as inhibitors of atr kinase and combination therapies thereofVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 0967US11035866B2Biomarkers for seizuresUNIV PENNSYLVANIA·Filed 2018·Granted Jun 15, 2021·0 cites·6 claims
- 1067US2023251276A1Biomarkers and methods for detection of seizures and epilepsyCOGNIZANCE BIOMARKERS LLC·Filed 2023·Application pending·0 cites
- 1165US2023106592A1Method for treating cancer using a combination of dna damaging agents and atr inhibitorsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1265US2020390761A1Treating cancer with atr inhibitorsVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 1361US9772335B2Biomarkers for seizuresUNIV PENNSYLVANIA·Filed 2016·Granted Sep 26, 2017·0 cites·6 claims
- 1459US2011269732A1Drug discovery methodsVERTEX PHARMA·Filed 2009·Application pending·0 cites
- 1559US2016139153A1Biomarkers for seizuresUNIV PENNSYLVANIA·Filed 2015·Application pending·0 cites
- 1657US2014044802A1Compounds useful as inhibitors of atr kinase and combination therapies thereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1755US11464774B2Method for treating cancer using a combination of DNA damaging agents and ATR inhibitorsVERTEX PHARMA·Filed 2016·Granted Oct 11, 2022·0 cites·14 claims
- 1854US2013331329A1Biomarkers for seizuresPOLLARD JOHN ROBERT·Filed 2012·Application pending·0 cites
- 1951US2009062302A1Jak2 Tyrosine Kinase InhibitionBUSER-DOEPNER CAROLYN A·Filed 2007·Application pending·0 cites
- 2050US2014141099A1Drug discovery methodsVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 2150US2019011461A1Biomarkers and methods for detection of seizures and epilepsyEVOGEN INC·Filed 2017·Application pending·0 cites
- 2248US2013089626A1Treating Cancer with ATR InhibitorsPOLLARD JOHN ROBERT·Filed 2012·Application pending·0 cites
- 2346US2021196751A1Methods of cancer treatment using an atr inhibitorVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 2442US2010324063A1Jak2 tyrosine kinase inhibitionBUSER-DOEPNER CAROLYN A·Filed 2010·Application pending·0 cites
- 2539US2009298844A1Abl kinase inhibitionPOLLARD JOHN·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Robert Pollard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →